期刊文献+

地奥司明片在健康人体内的药动学 被引量:3

Pharmacokinetics of diosmin tablets in healthy volunteers
原文传递
导出
摘要 目的:建立人血浆中地奥司明代谢物香叶木素浓度的LC-MS/MS测定法,研究地奥司明片在健康人体内的药动学。方法:采用自身双交叉试验设计,22例中国男性健康受试者,分别单剂量和bid连续7 d多剂量口服地奥司明片900 mg,并于单剂量和多剂量最后一次给药后0-96 h间隔采集静脉血分离血浆样品待测。经β-葡萄糖醛酸酶酶解和甲基叔丁基醚-异丙醇(1∶1)提取处理,LC-MS/MS法测定血浆中香叶木素的浓度,用DAS 2.0软件计算药动学参数。结果:建立的LC-MS/MS法测定血浆香叶木素浓度在0.1-40 ng·mL^-1范围内线性关系良好,最低定量限为0.1 ng·mL^-1,经方法验证符合生物样品测定要求。测得受试者900 mg单剂量和多剂量给药后的主要药动学参数如下:Cmax分别为(4.2±3.8)和(10.3±6.3)ng·mL^-1,Tmax分别为(18.7±9.9)和(6.1±7.0)h,t1/2分别为(60.2±85.7)和(102.5±174.8)h,AUC0-96分别为(185.4±166.2)和(277.6±143.8)h·ng·mL^-1,AUC0-∞分别为(237.2±170.5)和(551.0±606.4)h·ng·mL^-1。结论:建立的LC-MS/MS法专属、灵敏、准确,适用于地奥司明片的药动学研究。 Objective:To establish an LC-MS/MS method for the determination of diosmetin(metabolite of diosmin) in human plasma,and to investigate the pharmacokinetics of diosmin tablets in healthy volunteers.Methods:In a randomized and crossover study,twenty-two male Chinese volunteers were given a single or multiple(bid for seven days) oral dose of 900 mg diosmin tablets after an overnight fast.Then,venous blood was collected at predetermined time points(0 - 96 h).The plasma samples separated were determined by an established LC-MS /MS method after enzyme hydrolysis with β-glucuronidase and extraction by methyl tertbutyl ether-isopropranol.The pharmacokinetic parameters of diosmetin were calculated by DAS 2.0 software.Results:The established LC-MS /MS method had a linear calibration range over 0.1 - 40 ng·mL^- 1 with an LLOQ of 0.1 ng·mL^- 1 for diosmetin in human plasma.The method validation met the criteria for bio-samples determination.The main pharmacokinetic parameters of diosmin tablets after 900 mg single or multiple oral dose were as follows:Cmax(4.2 ± 3.8) and(10.3 ±6.3) ng·mL^- 1,Tmax(18.7 ±9.9) and(6.1 ±7.0) h,t1 /2(60.2 ±85.7) and(102.5 ±174.8) h,AUC0 ~ 96(185.4 ±166.2) and(277.6 ±143.8) h·ng·mL^- 1,and AUC0 - ∞(237.2 ±170.5) and(551.0 ±606.4) h·ng·mL^- 1.Conclusion:The LC-MS /MS method is proved to be specific,sensitive and accurate,and can be applied in pharmacokinetic study of diosmin tablets.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第14期1674-1678,共5页 Chinese Journal of New Drugs
关键词 地奥司明片 香叶木素 酶解 高效液相色谱-串联质谱法 药动学 diosmin tablets diosmetin enzymatic hydrolysis LC-MS/MS pharmacokinetics
  • 相关文献

参考文献11

  • 1Diosmin (monograph)[J].Altern Med Rev, 2004, 9(3):308-311.
  • 2LYSENG-WILLIAMSON KA, PERRY CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids[J]. Drugs, 2003, 63(1):71-100.
  • 3李树民,于定荣,张琳.地奥司明片的生物等效性[J].中国临床药学杂志,2007,16(6):344-347. 被引量:4
  • 4陈敏,郑仁礼.双波长HPLC法研究地奥司明在体内的药代动力学[J].现代中西医结合杂志,2012,21(6):636-638. 被引量:2
  • 5KANAZE FI, BOUNARTZI MI, NIOPAS I. A validated HPLC determination of the flavone aglycone diosmetin in human plasma[J]. Biomed Chromatogr, 2004, 18(10): 800-804.
  • 6SPANAKIS M, KASMAS S, NIIOPAS I. Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic reduction of diosmetin to hesperetin[J]. Biomed Chromatogr, 2009, 23(2): 124-131.
  • 7文爱东,吴寅,杨春娥,杨志福,王莉,王志睿,周伦.地奥司明片在健康人体内的药物动力学[J].中国药师,2007,10(7):632-634. 被引量:15
  • 8CAMPANERO MA, ESCOLAR M, PEREZ G, et al. Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study[J]. J Pharm Biomed Anal, 2010, 51(4): 875-881.
  • 9国家药典委员会. 药物制剂人体生物利用度和生物等效性研究技术指导原则[S]//中华人民共和国药典: 二部. 北京: 中国医药科技出版社, 2010: 附录XIX B 195.
  • 10SILVESTRO L, TARCOMNICU I, DULEA C, et al. Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry[J]. Anal Bioanal Chem, 2013, 405(25): 8295-8310.

二级参考文献16

  • 1Dieterling P.Contribution of anorectal manometry to the treatment of hemorrhoids[J].Phlebologie,1992,21(Suppl 2):57-60.
  • 2Buckshee K,Takkar D,Aggarwal N.Micronized flavonoid therapy in internal hemorrhoids of pregnancy[J].Int J Gynaecol Obstet,1997,57(2):145-151.
  • 3Dianae G,Catanzaro M,Ferrara A,et al.Actitity diosnin in the Treatment of Homerrhoids[J].Clin Ter,2000,151(5):341.
  • 4Meshikhes AW.Daflon for haerrhoids:apropective,multi centre observational study[J].Surgeon,2004,2(6):335.
  • 5Cesaone MR,Belcero G,Rohdewld P,et al.Comparison of pycnogenol and daflon in treating chronic venous insufficiency:aprospective,controlled study[J].Clin Appl Thrornb Hemost,2006,12(2):205.
  • 6Del Rio JA,Fuster MD,Gomez P,et al.Citrus Limon:a source of flavonoids of pharmaceutical interest[J].Food Chemistry,2004,84:457-461
  • 7Cesarone MR,BeLcaro G,Pellegrini L,et al.Venoruton vs Daflon:evaluation of effects on quality of life in chronic venous insufficiency[J].Angiology,2006,57(2):131-138
  • 8Garner RC,Garner JV,Gregory S,et al.Comparison of the absorption of micronized (daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting[J].J Pharm Sci,2002,91 (1):32-40
  • 9Cova D,De AngeLis L,Giavarini F,et al.Pharmacokinetics and metabolism of oral diosmin in healthy volunteers[J].Int J Clin Pharmacol Ther Toxicol,1992,30(1):29-33
  • 10Feras IK,Melpomeni IB,Ioannis N.A validated HPLC determination of the flavone aglycone diosmetin in human plasma[J].Biomed Chromatogr,2004,18:800-804

共引文献18

同被引文献71

  • 1周璐.地奥司明[J].医药导报,2007,26(10):1235-1236. 被引量:43
  • 2DIETERLINGP.Contribution of anore et al.Manometry to the treatment of the morrhoids[J].Phlebologie,1992,21(Suppl2):57-60.
  • 3HOYH.Prospective randomized controlledtrial of Daflon500mg to reduce bleeding after haemorrhoidectomy[J].BrJ Surg,1995,82:1034-1035.
  • 4BUCKSHEEK.Micronized flavonoid therapy in internal hemorrhoids o pregnancy[J].JGynecolO bstdtB iolReprod,1997,57:145-151.
  • 5Dieterling P,Contribution of anorectal manometry to the treatment of hemorrhoids[J].Phlebologie,1992,21(Suppl 2):57-60.
  • 6Buckshee K,Takkar D,Aggarwal N.Micronized flavonoid therapy in internal hemorrhoids of pregnancy[J].Int J Gynaecol Obstet,1997,57(2):145-151.
  • 7Dianae G,Catanzaro M,Ferrara A,et al.Actitity diosnin in the Treatment of Homerrhoids[J].Clin Ter,2000,151(5):341.
  • 8Meshikhes AW.Daflon for haerrhoids:apropective,multi-centre observational study[J].Surgeon,2004,2(6):335.
  • 9Ho YH,Tan M,Seow-Choen F.Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids:r andomized controlled trial[J].Dis Colon Rectum,2000,43(1):66-69.
  • 10刘贻泉.地奥司明治疗中老年前列腺增生的疗效[J].Heald of Medieine,28(Supp l):54.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部